Navigation Links
Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
Date:2/1/2008

WASHINGTON, Feb. 1 /PRNewswire/ -- Two new analyses of observational data presented at today's Community Oncology Conference reported a significantly lower proportion of patients receiving transfusions when erythropoiesis- stimulating agents (ESAs) treatment was initiated at hemoglobin (Hb) levels between 10 to 11 grams per deciliter (g/dL) of blood compared with patients having Hb levels less than 10 g/dL prior to ESA treatment. In addition, wide variability in hemoglobin levels prior to transfusion was reported.

These analyses were conducted using data from the ongoing prospective, observational Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry, sponsored by Centocor Ortho Biotech Services, L.L.C.

"Observational data reflect real-world clinical practice and therefore these findings are important in helping to understand transfusion patterns," said Kay Larholt, Sc.D., Vice President, Biometrics at Abt Associates, a biopharmaceutical research and consulting firm, and lead author of both analyses presented today. "The analyses indicate that the presence of a lower hemoglobin when ESA therapy was initiated was associated with a higher need for transfusion, and suggest initiation at a hemoglobin between 10 to 11 g/dL may reduce the need for transfusion."

Methodology and Results

For both analyses, real-world data on ESA-treated patients in 48 U.S. oncology clinics were analyzed from the DOSE Registry. Data were collected from participating hospital- and community-based outpatient practices between December 2003 and July 2007.

In the first analysis of 969 patients, transfusion data were analyzed from adult chemotherapy-treated oncology patients that received at least two ESA doses. Results of the analysis were as follows:

-- A significantly greater proportion of chemotherapy-treated patients

received transfusions when ESA treatment was initiated at Hb levels

below 10
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
2. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
3. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
4. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
5. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
6. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
7. ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
8. Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
9. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
10. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
11. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013   BioCision , a ... and handling in many areas of medical and ... patents by the U.S. Patent Office that apply ... to standardize sample handling to ensure the consistency ... common laboratory procedures. Patent number ...
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... Amerivet Solutions, LLC ( AMERIVET ), ... government from Federal to Municipal, is pleased to ... include complex metal design and fabrication manufacturing. "We ... aluminum parts for the Defense Logistics Agency (DLA) ... service government contracts," states Richard Bergen , ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Drug Patent Watch 2Drug Patent Watch 3Amerivet Solutions Expands to Manufacture Complex Metal Designs 2
(Date:6/20/2013)... Dr. Ramtin Kassir is one of ... and NYC and a top cosmetic surgeon in ... is to provide individualized care for a broad spectrum of ... surgeon is partnering with the new and emerging business consultancy ... its specialized needs. , "We are partnering with Tom and ...
(Date:6/20/2013)... June 20, 2013 Volume based manufacturing ... dramatically reduce the retail pricing of both it's WHEY ... replacement products. , Premier Natural Health’s whey protein ... food sources and are formulated to help maintain healthy ... intake and slow the aging process. , Ideal ...
(Date:6/20/2013)... Sydney, Australia (PRWEB) June 20, 2013 ... , research was presented recently, that can show similarities ... food. This could explain the current global obesity ... be addicted to food just as one can be ... Neuroscience and Applied Cognitive Science at the University of ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 With the ... has put together their winter season Santiago day ... adventure day trips in and around Santiago this season, ... into Chile's Central Andes for backcountry skiing, challenging rock ... those who have always dreamed of skiing in ...
(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 The ... American bands in the country and folk music genre. This ... Brown (who is the lead vocals and guitarist), Jimmy De ... Hopkins (the bass guitarist and in vocals), Coy Bowles (guitarist ... de los Reyes (percussionist). The band was formed in ...
Breaking Medicine News(10 mins):Health News:Celebrity Plastic Surgeon Dr. Kassir Teams Up With X Factor Selling Systems to Enhance Patient Experience 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:Research Suggests That Unhealthy Food Addiction Could Explain Global Obesity Epidemic 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:Zac Brown Band Tickets for Raleigh, Columbia, Darien Center, Gilford, Minneapolis, Holmdel, Pittsburgh, Camden, Atlanta, Boston, Bethel, Toronto & Hartford Now Available 2
... ISTA,Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced ... 30, 2008, after the U.S. markets,close. ISTA will host ... results at 4:30 p.m. Eastern Time on April 30., ... Canadian participants may,dial 866-362-5158; international participants may dial 617-597-5397. ...
... Camp-based therapy proved more beneficial than individual grief counseling, ... Children who experience the unexpected death of a parent ... (PTSD), a finding that has major implications for helping ... researchers. , "Often children who have lost a parent ...
... melanomas die at nearly twice the rate of people with ... researchers at the University of North Carolina at Chapel Hill ... the U.S. confirms that survival rates differ depending on where ... die at a rate 1.84 times higher than those with ...
... millimeters in diameter appear more likely to be melanomas ... April issue of Archives of Dermatology, one of the ... currently used by dermatologists to screen for melanoma are ... screen for melanoma, according to background information in the ...
... Howard G. Smith,announces a May 12, 2008, deadline to ... action lawsuit filed on behalf of all persons who,purchased ... the "Company") (Nasdaq: VRTX ) between June 12, ... shareholder lawsuit,is pending in the United States District Court ...
... Decisions on Bottom Line Return at 3rd Annual ... Pharmaceutical Market Research Summit, NEW ... the pharmaceutical analytics company Eularis, will be,delivering a presentation on ... Research and Decisions on Bottom Line Return., ...
Cached Medicine News:Health News:Treating PTSD Helps Kids Deal With Loss 2Health News:Most lethal melanomas are on scalp and neck 2Health News:Larger skin lesions appear more likely to be melanomas 2Health News:Eularis to Address Making the Right Research Decision for ROI 2
... The Air-Stirrup Plus combines the ... an ankle wrap. In addition, a ... each Air-Stirrup Plus and provides information ... components of ankle sprain management.,Each Air-Stirrup ...
Classic black cast boot with unisex styling...
Ideal for use with thinner casting materials such as polyester or fiberglass. Conforms to any casting material....
... Inc. Rheumatoid Factor (RF) IgM ELISA ... qualitative and semi-quantitative detection of RF ... test system is intended to be ... diagnosis of rheumatoid arthritis. This test ...
Medicine Products: